GGrantIndex
Sort

85,873 grants matching alzheimers

Improving Inclusivity of Alzheimer’s Disease and Related Dementias Research for Asian Americans and Latinx through Nationally Representative Hybrid Sampling.

$979,196
Sung-Hee Lee · University Of Michigan At Ann Arbor · R01 · FY2024 · AG

BRAIN HEALTH TOGETHER: A LIVE-STREAMING GROUP-BASED DIGITAL PROGRAM

$979,126
Cynthia Louise Benjamin · Together Senior Health, Inc. · R44 · FY2022 · AG

Planning an Adaptive Clinical Trial of Cognitive Training to Improve Function and Delay Dementia

$979,034
Jerri Edwards · University Of South Florida · U01 · FY2019 · AG

Molecular Mechanisms of the Blood Brain Barrier Function and Regulation

$979,016
Chenghua Gu · Harvard Medical School · R35 · FY2024 · NS

ALZHEIMER AMYLOIDOGENESIS WITH NEW METHODS

$979,007
Brigham And Women'S Hospital · P01 · FY2001 · AG

Cyclin-dependent kinase 5 (Cdk5) in Physiology and Pathology

$978,658
Harish C Pant · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS

Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease

$978,427
Bruce A Yankner · Harvard Medical School · R01 · FY2017 · AG

GuMI: New In Vitro Platforms to Parse the Human Gut Epithelial-Microbiome-Immune Axis

$978,402
Rebecca L Carrier · Northeastern University · R01 · FY2019 · EB

SilverBills: A Financial and Legal Tech Tool for Caregivers

$978,137
Marci Lobel-Esrig · Silverbills Inc. · R44 · FY2022 · AG

Multi-site longitudinal Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS)

$978,121
Chris Berka · Advanced Brain Monitoring, Inc. · R44 · FY2023 · AG

Cellular And Molecular Pathogenesis Of Alzheimer

$978,069
Mark Mattson · National Institute On Aging · ZIA · FY2015 · AG

Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology

$978,033
Monica Lizet Moya · Lawrence Livermore National Security, Llc · R61 · FY2022 · HL

Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD

$977,956
William C Raschke · Virogenics, Inc. · R44 · FY2018 · AI

Objective Physical Activity and Cardiovascular Health in Women Aged 80 and Older

$977,906
Andrea Z. Lacroix · Fred Hutchinson Cancer Research Center · R01 · FY2014 · HL

Gene expression in the human brain

$977,828
Mark Cookson · National Institute On Aging · ZIA · FY2022 · AG

Immunology of aging and immunotherapy of aging-associated diseases

$977,820
Bira Arya · National Institute On Aging · ZIA · FY2015 · AG

Highly sensitive immunoassay for determination of biomarkers for neurodegenerative diseases

$977,713
Simon Bystryak · Allied Innovative Systems, Llc · R44 · FY2023 · AG

Organization and architecture of a Center for cellular resolution analysis of Alzheimer's disease

$977,646
Ed Lein · Allen Institute · U19 · FY2024 · AG

Imaging of Cognition, Learning and Memory in Aging

$977,369
Yaakov Stern · Columbia University Health Sciences · R01 · FY2020 · AG

Longitudinal Cognitive ERP studies: Advancement for AD Clinical Trials

$977,234
John M Olichney · University Of California At Davis · R01 · FY2017 · AG

The impact of bilingualism on cognitive reserve/resilience using socio-demographically and linguistically diverse populations

$977,175
Boon Lead Tee · University Of California, San Francisco · R01 · FY2024 · AG

Development of DYRK1A allosteric modulator for the treatment of Alzheimer's Disease

$976,999
Gian Luca Araldi · Avanti Biosciences, Inc. · SB1 · FY2022 · AG

Novel Mechanisms of NSAID Action in Alzheimer's Disease

$976,709
Edward H. Koo · University Of California, San Diego · P01 · FY2012 · AG

An Integrated Genomic Approach to Alzheimer Disease

$976,433
Duke University · R01 · FY2004 · AG

Preeclampsia and the Brain: Small vessel disease and cognitive function in early midlife

$976,170
Janet M Catov · Magee-Women'S Res Inst And Foundation · R01 · FY2025 · AG